
Diogo Dalot Reportedly to Have Manchester United Medical 'In the Next Few Days'
Porto starlet Diogo Dalot will have a medical with Manchester United "in the next few days."
That's according to A Bola (h/t Sport Witness' Lucas Sposito), and the Portuguese outlet added that Dalot will sign a five-year deal at Old Trafford following his medical, with United paying €24 million (£21 million) to sign him.
As ESPN FC's Rob Dawson reported, unnamed sources have said United are prepared to pay a premium for Dalot in order to secure his signature before Friday, when his €20 million (£17.6 million) release clause is said to activate.
That would allow them to snap him up before the likes of Bayern Munich and Barcelona—who are also interested in the 19-year-old—enter the race when it kicks in.
However, there are some conflicting reports on the matter. O Jogo said the clause comes into effect a on July 1 (h/t Sposito), while Record reported the premium is actually a request on Dalot's part to smooth over his exit from the club.
Nevertheless, the Red Devils are thought to be in negotiations with the Portuguese champions over a deal for the full-back, who can play on either side of the defence.
Dalot has made just eight senior appearances for Porto, one of which was in their 0-0 draw at Liverpool in the UEFA Champions League in March.
United manager Jose Mourinho has had his eye on him, though, per James Robson of the Manchester Evening News:
Football writer Liam Canning is unfamiliar with the youngster but trusts Mourinho's instincts:
The Red Devils are in need of reinforcements at full-back, with Matteo Darmian and Daley Blind expected to leave, Antonio Valencia and Ashley Young both turning 33 this summer and Mourinho appearing to have little trust in Luke Shaw.
Portuguese football expert Jan Hagen gave the lowdown on Dalot's qualities:
He seems like a promising capture, one who could inject some youthful energy into the defence and who has the potential to grow into an excellent player given time.
A fee in excess of €20 million is a hefty price to pay for a player with just eight senior appearances under his belt, but in today's market, it could be a worthwhile investment if it helps them beat their European competitors to a long-term acquisition.



.jpg)
.jpg)
.jpg)




